These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36639515)

  • 1. Targeting erythrocyte-mediated hypoxia to alleviate lung injury induced by pyrrolizidine alkaloids.
    Song Z; Lian W; He Y; Zhang C; Lin G
    Arch Toxicol; 2023 Mar; 97(3):819-829. PubMed ID: 36639515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal exposure to pyrrolizidine alkaloids induced hepatotoxicity and pulmonary injury in fetal rats.
    Guo Y; Xiao D; Yang X; Zheng J; Hu S; Wu P; Li X; Kou H; Wang H
    Reprod Toxicol; 2019 Apr; 85():34-41. PubMed ID: 30771476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Study of Hepatotoxicity of Pyrrolizidine Alkaloids Retrorsine and Monocrotaline.
    Yang X; Li W; Sun Y; Guo X; Huang W; Peng Y; Zheng J
    Chem Res Toxicol; 2017 Feb; 30(2):532-539. PubMed ID: 28095673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung injury induced by pyrrolizidine alkaloids depends on metabolism by hepatic cytochrome P450s and blood transport of reactive metabolites.
    He Y; Lian W; Ding L; Fan X; Ma J; Zhang QY; Ding X; Lin G
    Arch Toxicol; 2021 Jan; 95(1):103-116. PubMed ID: 33033841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary toxicity is a common phenomenon of toxic pyrrolizidine alkaloids.
    Song Z; He Y; Ma J; Fu PP; Lin G
    J Environ Sci Health C Toxicol Carcinog; 2020; 38(2):124-140. PubMed ID: 32500835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyrrolizidine Alkaloid-Induced Hepatotoxicity Associated with the Formation of Reactive Metabolite-Derived Pyrrole-Protein Adducts.
    Ma J; Li M; Li N; Chan WY; Lin G
    Toxins (Basel); 2021 Oct; 13(10):. PubMed ID: 34679016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Red blood cells augment transport of reactive metabolites of monocrotaline from liver to lung in isolated and tandem liver and lung preparations.
    Pan LC; Lamé MW; Morin D; Wilson DW; Segall HJ
    Toxicol Appl Pharmacol; 1991 Sep; 110(2):336-46. PubMed ID: 1909819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic effects of pyrrolizidine alkaloids and lipopolysaccharide on preterm delivery and intrauterine fetal death in mice.
    Guo Y; Ma Z; Kou H; Sun R; Yang H; Smith CV; Zheng J; Wang H
    Toxicol Lett; 2013 Aug; 221(3):212-8. PubMed ID: 23831946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms and pathology of monocrotaline pulmonary toxicity.
    Wilson DW; Segall HJ; Pan LC; Lamé MW; Estep JE; Morin D
    Crit Rev Toxicol; 1992; 22(5-6):307-25. PubMed ID: 1489509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fasting augments pyrrolizidine alkaloid-induced hepatotoxicity.
    Ma J; Zhang C; He Y; Chen X; Lin G
    Arch Toxicol; 2022 Feb; 96(2):639-651. PubMed ID: 34792613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical application of pyrrole-hemoglobin adducts as a biomarker of pyrrolizidine alkaloid exposure in humans.
    Ma J; Zhang W; He Y; Zhu L; Zhang C; Liu J; Ye Y; Zhuge Y; Lin G
    Arch Toxicol; 2021 Feb; 95(2):759-765. PubMed ID: 33210216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developing urinary pyrrole-amino acid adducts as non-invasive biomarkers for identifying pyrrolizidine alkaloids-induced liver injury in human.
    Zhu L; Zhang C; Zhang W; Xia Q; Ma J; He X; He Y; Fu PP; Jia W; Zhuge Y; Lin G
    Arch Toxicol; 2021 Oct; 95(10):3191-3204. PubMed ID: 34390356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex difference in monocrotaline-induced developmental toxicity and fetal hepatotoxicity in rats.
    Luo J; Yang X; Qiu S; Li X; Xiang E; Fang Y; Wang Y; Zhang L; Wang H; Zheng J; Guo Y
    Toxicology; 2019 Apr; 418():32-40. PubMed ID: 30825512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic activation of the tumorigenic pyrrolizidine alkaloid, retrorsine, leading to DNA adduct formation in vivo.
    Wang YP; Fu PP; Chou MW
    Int J Environ Res Public Health; 2005 Apr; 2(1):74-9. PubMed ID: 16705803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The comparative metabolism of the four pyrrolizidine alkaloids, seneciphylline, retrorsine, monocrotaline, and trichodesmine in the isolated, perfused rat liver.
    Yan CC; Cooper RA; Huxtable RJ
    Toxicol Appl Pharmacol; 1995 Aug; 133(2):277-84. PubMed ID: 7645024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyrrole-Hemoglobin Adducts, a More Feasible Potential Biomarker of Pyrrolizidine Alkaloid Exposure.
    Ma J; Ruan J; Chen X; Li D; Yao S; Fu PP; Ye Y; Gao H; Wang J; Lin G
    Chem Res Toxicol; 2019 Jun; 32(6):1027-1039. PubMed ID: 31012303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotoxicity of the pyrrolizidine alkaloid monocrotaline following subchronic administration to C57Bl/6 mice.
    Deyo JA; Kerkvliet NI
    Fundam Appl Toxicol; 1990 May; 14(4):842-9. PubMed ID: 2113877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of formation of pyrrole-ATP synthase subunit beta adduct in pyrrolizidine alkaloid-induced hepatotoxicity.
    Lu Y; Ma J; Song Z; Ye Y; Fu PP; Lin G
    Arch Toxicol; 2018 Nov; 92(11):3403-3414. PubMed ID: 30244272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First evidence of pyrrolizidine alkaloid N-oxide-induced hepatic sinusoidal obstruction syndrome in humans.
    Yang M; Ruan J; Gao H; Li N; Ma J; Xue J; Ye Y; Fu PP; Wang J; Lin G
    Arch Toxicol; 2017 Dec; 91(12):3913-3925. PubMed ID: 28620673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxicity of pyrrolizidine alkaloid in human hepatic parenchymal and sinusoidal endothelial cells: Firm evidence for the reactive metabolites mediated pyrrolizidine alkaloid-induced hepatotoxicity.
    Yang M; Ruan J; Fu PP; Lin G
    Chem Biol Interact; 2016 Jan; 243():119-26. PubMed ID: 26365561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.